Literature DB >> 26829536

Extended-spectrum β-lactamases, transferable quinolone resistance, and virulotyping in extra-intestinal E. coli in Uruguay.

Rafael Vignoli1, Virginia García-Fulgueiras, Nicolás F Cordeiro, Inés Bado, Verónica Seija, Paula Aguerrebere, Gabriel Laguna, Lucía Araújo, Cristina Bazet, Gabriel Gutkind, José Chabalgoity.   

Abstract

INTRODUCTION: To characterize extended-spectrum β-lactamases (ESBLs) and plasmid-mediated quinolone resistance (PMQR) genes in Escherichia coli isolates obtained from extra-intestinal samples in three Uruguayan hospitals.
METHODOLOGY: Fifty-five ESBL-producing E. coli isolates were studied. Virulence genes, ESBLs, and PMQR genes were detected by polymerase chain reaction. ESBL-producing isolates were compared by pulsed-field gel electrophoresis. Multi-locus sequence typing was also performed on 13 selected isolates.
RESULTS: Thirty-seven isolates harbored blaCTX-M-15 (67.3%), eight blaCTX-M-2 (14.6%), five blaCTX-M-14 (9.1%), three carried both blaCTX-M-2 and blaCTX-M-14, one blaCTX-M-9, and one blaCTX-M-8. Among the CTX-M-15 producers, 92% belonged to sequence types ST131 and ST405, and carried aac(6')Ib-cr as well. Isolates harboring blaCTX-M-2, blaCTX-M-14, blaCTX-M-9, or blaCTX-M-8 were found to be genetically unrelated.
CONCLUSIONS: The successful dissemination of CTX-M-15-producing E.coli isolates seems to be linked to the spreading of high-risk clones and horizontal gene transfer. A trade-off between carrying more antibiotic resistance and less virulence-related genes could partially account for the evolutionary advantages featured by successful clones.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26829536     DOI: 10.3855/jidc.6918

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  VIM-2-Producing Pseudomonas spp. in Uruguay: Sequence Types, Pulsotypes, and Class 1 Integrons Including New Variable Regions Featuring blaVIM-2 and blaGES-7.

Authors:  Romina Papa Ezdra; Inés Bado; Nicolás Cordeiro; Claudia Gutierrez; Patricia Hitateguy; Verónica Seija; Rafael Vignoli
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

2.  Imported One-Day-Old Chicks as Trojan Horses for Multidrug-Resistant Priority Pathogens Harboring mcr-9, rmtG, and Extended-Spectrum β-Lactamase Genes.

Authors:  Nadia Coppola; Nicolás F Cordeiro; Gustavo Trenchi; Fernanda Esposito; Bruna Fuga; Danny Fuentes-Castillo; Nilton Lincopan; Andrés Iriarte; Inés Bado; Rafael Vignoli
Journal:  Appl Environ Microbiol       Date:  2021-11-03       Impact factor: 5.005

3.  Transferable Resistance to Highest Priority Critically Important Antibiotics for Human Health in Escherichia coli Strains Obtained From Livestock Feces in Uruguay.

Authors:  Nadia Coppola; Bibiana Freire; Ana Umpiérrez; Nicolás F Cordeiro; Pablo Ávila; Gustavo Trenchi; Gustavo Castro; María Laura Casaux; Martín Fraga; Pablo Zunino; Inés Bado; Rafael Vignoli
Journal:  Front Vet Sci       Date:  2020-11-19

Review 4.  Extended-Spectrum Beta-Lactamases Producing Escherichia coli in South America: A Systematic Review with a One Health Perspective.

Authors:  Carlos Bastidas-Caldes; Daniel Romero-Alvarez; Victor Valdez-Vélez; Roberto D Morales; Andrés Montalvo-Hernández; Cicero Gomes-Dias; Manuel Calvopiña
Journal:  Infect Drug Resist       Date:  2022-09-30       Impact factor: 4.177

5.  Zoonotic Potential and Antibiotic Resistance of Escherichia coli in Neonatal Calves in Uruguay.

Authors:  Ana Umpiérrez; Inés Bado; Martín Oliver; Sofía Acquistapace; Analía Etcheverría; Nora Lía Padola; Rafael Vignoli; Pablo Zunino
Journal:  Microbes Environ       Date:  2017-09-12       Impact factor: 2.912

6.  The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections.

Authors:  Robab Azargun; Mohammad Reza Sadeghi; Mohammad Hossein Soroush Barhaghi; Hossein Samadi Kafil; Fatemeh Yeganeh; Mahin Ahangar Oskouee; Reza Ghotaslou
Journal:  Infect Drug Resist       Date:  2018-07-23       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.